Department of Medical Biochemistry and Molecular Biology, Institute of Biomedicine, University of Oulu, Finland.
Mitochondrion. 2009 Nov;9(6):394-401. doi: 10.1016/j.mito.2009.07.001. Epub 2009 Jul 17.
Seven of the 45 subunits of mitochondrial NADH:ubiquinone oxidoreductase (complex I) are mitochondrially encoded and have been shown to harbor pathogenic mutations. We modeled the human disease-associated mutations A4136G/ND1-Y277C, T4160C/ND1-L285P and C4171A/ND1-L289M in a highly conserved region of the fourth matrix-side loop of the ND1 subunit by mutating homologous amino acids and surrounding conserved residues of the NuoH subunit of Escherichia coli NDH-1. Deamino-NADH dehydrogenase activity, decylubiquinone reduction kinetics, hexammineruthenium (HAR) reductase activity, and the proton pumping efficiency of the enzyme were assayed in cytoplasmic membrane preparations. Among the human disease-associated mutations, a statistically significant 22% decrease in enzyme activity was observed in the NuoH-L289C mutant and a 29% decrease in the double mutant NuoH-L289C/V297P compared with controls. The adjacent mutations NuoH-D295A and NuoH-R293M caused 49% and 39% decreases in enzyme activity, respectively. None of the mutations studied significantly affected the K(m) value of the enzyme for decylubiquinone or the amount of membrane-associated NDH-1 as estimated from the HAR reductase activity. In spite of the decrease in enzyme activity, all the mutant strains were able to grow on malate, which necessitates sufficient NDH-1 activity. The results show that in ND1/NuoH its fourth matrix-side loop is probably not directly involved in ubiquinone binding or proton pumping but has a role in modifying enzyme activity.
线粒体 NADH:泛醌氧化还原酶(复合物 I)的 45 个亚基中有 7 个是线粒体编码的,并且已经显示出具有致病性突变。我们通过突变大肠杆菌 NDH-1 的 NuoH 亚基中的同源氨基酸和周围保守残基,对人源疾病相关突变 A4136G/ND1-Y277C、T4160C/ND1-L285P 和 C4171A/ND1-L289M 进行建模。在细胞质膜制剂中测定脱氨 NADH 脱氢酶活性、癸基泛醌还原动力学、六氨合钌(HAR)还原酶活性和酶的质子泵效率。在与人源疾病相关的突变中,与对照相比,NuoH-L289C 突变体的酶活性显著降低了 22%,而双突变体 NuoH-L289C/V297P 的酶活性降低了 29%。相邻突变 NuoH-D295A 和 NuoH-R293M 分别导致酶活性降低了 49%和 39%。研究的突变均未显著影响酶对癸基泛醌的 K(m) 值或根据 HAR 还原酶活性估计的膜结合 NDH-1 的量。尽管酶活性降低,但所有突变株均能够在苹果酸上生长,这需要足够的 NDH-1 活性。结果表明,在 ND1/NuoH 中,其四元基质侧环可能不直接参与泛醌结合或质子泵,但在修饰酶活性方面具有作用。